Pharmacokinetic and Pharmacodynamic Modeling of an Anti–Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma (Q39898226)
scientific article published on February 23, 2010
Language:
Current Data About Pharmacokinetic and Pharmacodynamic Modeling of an Anti–Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma
(P31) (Q13442814)
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

(P304) 1652-1661
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

(P407) (Q1860)

(P433) 5
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

(P478) 16
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

(P577) Tuesday, February 23, 2010
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

(P921) (Q194908)

(Q79460)
(P887)

(Q3960572)
(P887)

(Q422248)
(P887)

(Q323936)
(P887)

(Q725307)
(P887)

(P953) https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Pharmacokinetic_and_Pharmacodynamic_Modeling_of_an_Anti_Interleukin-6_Chimeric_Monoclonal_Antibody_Siltuximab_in_Patients_with_Metastatic_Renal_Cell_Carcinoma/22441839/1/files/39892722.pdf
(P2701)
(P6954)
(P248)
(P698) 20179212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20179212
(P813) Tuesday, May 13, 2025

http://clincancerres.aacrjournals.org/cgi/content/abstract/16/5/1652
(P6954)
(P248)
(P698) 20179212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20179212
(P813) Tuesday, May 13, 2025

https://aacrjournals.org/clincancerres/article-pdf/16/5/1652/1995318/1652.pdf
(P2701)
(P248)
(P356) 10.1158/1078-0432.CCR-09-2581
(P854) https://api.crossref.org/works/10.1158/1078-0432.CCR-09-2581
(P813) Tuesday, May 13, 2025

(P1433) (Q332253)
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

(P1476) "Pharmacokinetic and pharmacodynamic modeling of an anti-interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma" (language: en)
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

"Pharmacokinetic and Pharmacodynamic Modeling of an Anti–Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma" (language: en)
(P248)
(P356) 10.1158/1078-0432.CCR-09-2581
(P854) https://api.crossref.org/works/10.1158/1078-0432.CCR-09-2581
(P813) Tuesday, May 13, 2025

(P2093) Thomas Puchalski
(P1545) 1
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

Uma Prabhakar
(P1545) 2
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

Qun Jiao
(P1545) 3
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

Birge Berns
(P1545) 4
(P248)
(P698) 20179212
(P813) Friday, September 15, 2017

Hugh M. Davis
(P1545) 5
(P248)
(P698) 20179212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20179212
(P813) Tuesday, May 13, 2025

(P2860) (Q41114764)
(P1545) 6
(P248)
(P356) 10.1158/1078-0432.CCR-09-2581
(P854) https://api.crossref.org/works/10.1158/1078-0432.CCR-09-2581
(P813) Tuesday, May 13, 2025

other details
description scientific article published on February 23, 2010

External Links
(P356) 10.1158/1078-0432.CCR-09-2581
(P698) 20179212